Evodiamine, a Novel NOTCH3 Methylation Stimulator, Significantly Suppresses Lung Carcinogenesis in Vitro and in Vivo

Lung cancer is a leading cause of cancer-related deaths worldwide. NOTCH3 signaling is mainly expressed in non-small cell lung carcinoma (NSCLC), and has been proposed as a therapeutic target of NSCLC. While, few agents for preventing or treating NSCLC via targeting NOTCH3 signaling are used in mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Tao, Yang, Xia, Deng, Jian-Hua, Huang, Qiu-Ju, Huang, Su-Chao, Zhang, Yan-Min, Zheng, Hong-Ming, Wang, Ying, Lu, Lin-Lin, Liu, Zhong-Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938359/
https://www.ncbi.nlm.nih.gov/pubmed/29765324
http://dx.doi.org/10.3389/fphar.2018.00434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938359/
https://www.ncbi.nlm.nih.gov/pubmed/29765324
http://dx.doi.org/10.3389/fphar.2018.00434

Ejemplares similares